H. Vuorinenmarkkola et H. Ykijarvinen, HYPERURICEMIA AND INSULIN-RESISTANCE, The Journal of clinical endocrinology and metabolism, 78(1), 1994, pp. 25-29
The associates of gout-obesity, hypertriglyceridemia, glucose intolera
nce, and hypertension, strikingly resemble those of insulin resistance
. In the present study we determined whether hyperuricemia is associat
ed with insulin resistance and, if so, whether this association can be
explained by other components of the syndrome. For this purpose we qu
antitated insulin sensitivity (euglycemic clamp) in 37 nondiabetic sub
jects (aged 30-68 yr) exhibiting varying degrees of the metabolic synd
rome (body mass index, 21.5-35.7 kg/m(2); serum triglycerides, 0.4-22.
0 mmol/L; high density lipoprotein cholesterol 0.38-1.86 mmol/L; blood
pressure, 190-100/116-60 mm Hg). In simple linear regression analysis
, the serum uric acid concentration (range, 182-568 mu mol/L) was inve
rsely correlated with insulin sensitivity (rate of glucose utilization
; r = -0.61; P < 0.001) and positively with serum triglycerides (r = 0
.68; P < 0.001), but not with body mass index, age, or the plasma gluc
ose concentration. In multiple linear regression analysis, both insuli
n sensitivity (P < 0.05) and serum triglycerides (P < 0.005) were inde
pendently associated with the serum uric acid concentration, and toget
her explained 50% of its variation. Addition of body mass index or age
to the model did not improve the degree of explanation. Acute elevati
on of serum triglycerides about 8-fold, of plasma FFA about g-fold, or
of serum insulin about 28-fold had no effect on the serum uric acid c
oncentration in healthy volunteers. The data indicate that hyperuricem
ia is indeed an inherent component of the metabolic syndrome and could
also be used as a simple marker of insulin resistance.